17:21 EDT Oruka Therapeutics (ORKA) files to sell 39.43M shares of common stock for holders
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORKA:
- Promising Future for Oruka Therapeutics: Buy Rating Backed by ORKA-002’s Market Potential and Strategic Expansion
- Oruka Therapeutics’ ORKA-002: Promising Alternative with Competitive Edge in Hidradenitis Suppurativa and Psoriasis
- Leerink sees greater opportunity for Oruka’s ORKA-002 after MoonLake news
- Oruka Therapeutics jumps 28% after MoonLake data miss
- Oruka Therapeutics Secures $180M in Private Placement